These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35821800)

  • 21. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
    Toback S; Galiza E; Cosgrove C; Galloway J; Goodman AL; Swift PA; Rajaram S; Graves-Jones A; Edelman J; Burns F; Minassian AM; Cho I; Kumar L; Plested JS; Rivers EJ; Robertson A; Dubovsky F; Glenn G; Heath PT;
    Lancet Respir Med; 2022 Feb; 10(2):167-179. PubMed ID: 34800364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study.
    Tang F; Hammel IS; Andrew MK; Ruiz JG
    Lancet Healthy Longev; 2022 Sep; 3(9):e589-e598. PubMed ID: 35935474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines for older adults.
    Cunningham AL; McIntyre P; Subbarao K; Booy R; Levin MJ
    BMJ; 2021 Feb; 372():n188. PubMed ID: 33619170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
    Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exclusive and dual influenza and COVID-19 vaccination among U.S. adults and adolescents in 2021.
    Nguyen KH; Zhao R; Chen S; Bednarczyk RA
    Ann Med; 2023 Dec; 55(1):2196436. PubMed ID: 37052255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-based biology and the rational design of influenza vaccination strategies.
    Klein SL; Pekosz A
    J Infect Dis; 2014 Jul; 209 Suppl 3(Suppl 3):S114-9. PubMed ID: 24966191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of sex on responses to influenza vaccines.
    Denly L
    Hum Vaccin Immunother; 2021 May; 17(5):1396-1402. PubMed ID: 33180651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies.
    Janssen C; Mosnier A; Gavazzi G; Combadière B; Crépey P; Gaillat J; Launay O; Botelho-Nevers E
    Hum Vaccin Immunother; 2022 Nov; 18(6):2131166. PubMed ID: 36256633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults.
    Bartley JM; Cadar AN; Martin DE
    Immunol Invest; 2021 Oct; 50(7):810-820. PubMed ID: 33830864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.
    Merani S; Kuchel GA; Kleppinger A; McElhaney JE
    Exp Gerontol; 2018 Jul; 107():116-125. PubMed ID: 28958701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination.
    Ralise AEG; Camargo TM; Marson FAL
    Hum Vaccin Immunother; 2023 Aug; 19(2):2234784. PubMed ID: 37449956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference.
    Choi MJ; Yu YJ; Kim JW; Ju HJ; Shin SY; Yang YJ; Cheong HJ; Kim WJ; Kim C; Kim HJ; Yoon SK; Park SJ; Gwak W; Lee JW; Kim B; Song JY
    Clin Microbiol Infect; 2024 May; 30(5):653-659. PubMed ID: 38253313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials.
    Kiely M; Tadount F; Lo E; Sadarangani M; Wei SQ; Rafferty E; Quach C; MacDonald SE
    J Epidemiol Community Health; 2023 Dec; 77(12):791-801. PubMed ID: 37734937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines for preventing influenza in the elderly.
    Demicheli V; Jefferson T; Di Pietrantonj C; Ferroni E; Thorning S; Thomas RE; Rivetti A
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004876. PubMed ID: 29388197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.
    Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G
    Front Immunol; 2021; 12():778679. PubMed ID: 34868051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
    Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
    Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
    Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.